Last reviewed · How we verify

NCT04921891

Is Perfusion Index an Indicator of Block Success in Ultrasound-guided Infraclavicular Brachial Plexus Block

Completed NA Last updated 10 June 2021
What this trial tests

NA trial testing Infraclavicular nerve block in Carpal Tunnel Syndrome in 30 participants. Completed in 30 October 2014.

Timeline
15 April 2014
Primary endpoint
15 April 2014
30 October 2014

Quick facts

Lead sponsorBakirkoy Dr. Sadi Konuk Research and Training Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment30
Start date15 April 2014
Primary completion15 April 2014
Estimated completion30 October 2014
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Who can join

Adults 18 to 75, any sex, with Carpal Tunnel Syndrome or Perfusion Index. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The infraclavicular nerve block, which is frequently preferred in upper extremity surgeries, provides additional advantages such as reduction in opioid consumption by providing analgesic effect in the postoperative period as welll. The success of peripheral nerve blocks is usually assessed by subjective feedback from the patient, and patient cooperation is needed. The aim of this study is to assess whether the perfusion index level, which can be measured noninvasively, can be a predictor of the infraclavicular block success.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Infraclavicular nerve block

Trials testing the same drug.

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other Bakirkoy Dr. Sadi Konuk Research and Training Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04921891.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing